Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis
Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether cyclophosphamide post bone marrow
transplant increases the rate of patients alive, in remission and without immunosuppression,
one year after transplant, when compared with the combination of methotrexate and calcineurin
inhibitor